Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement

Many acute and chronic lung disorders with variable degrees of pulmonary inflammation and fibrosis are collectively referred to as interstitial lung diseases (ILDs) or diffuse parenchymal lung diseases. Idiopathic pulmonary fibrosis (or cryptogenic fibrosing alveolitis) (IPF or CFA) is one of several idiopathic interstitial pneumonias. IPF is now recognized as a distinct clinical disorder. Despite major accomplishments in our understanding of the pathogenesis of lung fibrosis (l), the diagnosis and management of patients with IPF continues to pose significant challenges (24).

[1]  C. Siegel,et al.  Department of Laboratory Medicine, Bellin Memorial Hospital, Green Bay, Wisconsin , 1990 .

[2]  R. McAnulty,et al.  Pathogenesis of lung fibrosis and potential new therapeutic strategies. , 1995, Experimental nephrology.

[3]  P. Calverley,et al.  Cryptogenic fibrosing alveolitis with preserved lung volumes. , 1997, Thorax.

[4]  J. Allen,et al.  Diffuse interstitial pneumonitis. Clinicopathologic correlations in 20 patients treated with prednisone/azathioprine. , 1978, The American journal of medicine.

[5]  I. D. Johnston,et al.  Accuracy of diagnostic coding of hospital admissions for cryptogenic fibrosing alveolitis. , 1991, Thorax.

[6]  P. Haslam,et al.  Antinuclear antibody and lymphocyte responses to nuclear antigens in patients with lung disease , 1975 .

[7]  M. Schwarz,et al.  The impact of smoking on mechanical properties of the lungs in idiopathic pulmonary fibrosis and sarcoidosis. , 1991, The American review of respiratory disease.

[8]  J. Vergnon,et al.  CRYPTOGENIC FIBROSING ALVEOLITIS AND EPSTEIN-BARR VIRUS: AN ASSOCIATION? , 1984, The Lancet.

[9]  R. H. Ellis.  Familial Incidence of Diffuse Interstitial Pulmonary Fibrosis , 1965, Postgraduate medical journal.

[10]  R. Dowling,et al.  Comparison of open versus thoracoscopic lung biopsy for diffuse infiltrative pulmonary disease. , 1993, The Journal of thoracic and cardiovascular surgery.

[11]  D. Lynch,et al.  Conventional and high resolution computed tomography in the diagnosis of asbestos-related diseases. , 1989, Radiographics : a review publication of the Radiological Society of North America, Inc.

[12]  I. D. Johnston,et al.  The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom. , 1993, The European respiratory journal.

[13]  R. Thompson,et al.  Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. , 1993, Cytokine.

[14]  D. Libby,et al.  Immunogenetic and clinical findings in idiopathic pulmonary fibrosis. Association with the B-cell alloantigen HLA-DR2. , 2015, The American review of respiratory disease.

[15]  R G Gupta,et al.  Natural history and treated course of usual and desquamative interstitial pneumonia. , 1978, The New England journal of medicine.

[16]  N. Jones,et al.  Pattern of breathing during exercise in patients with interstitial lung disease. , 1983, Thorax.

[17]  I. D. Johnston,et al.  Mortality rates from cryptogenic fibrosing alveolitis in seven countries. , 1996, Thorax.

[18]  W. Black,et al.  The epidemiology of interstitial lung diseases. , 1994, American journal of respiratory and critical care medicine.

[19]  D. Hansell,et al.  Fibrosing alveolitis in systemic sclerosis: indices of lung function in relation to extent of disease on computed tomography. , 1997, Arthritis and rheumatism.

[20]  T. Colby,et al.  Histiocytosis X in the lung. , 1983, Human pathology.

[21]  R. Hubbard,et al.  Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study. , 1998, Chest.

[22]  D. Coultas.  Epidemiology of Idiopathic Pulmonary Fibrosis , 1993 .

[23]  C. Vesin,et al.  Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. , 1994, The European respiratory journal.

[24]  K. Sekizawa,et al.  Prognosis of idiopathic pulmonary fibrosis in patients with mucous hypersecretion. , 1991, The American review of respiratory disease.

[25]  L. Reid,et al.  DIFFUSE INTERSTITIAL PULMONARY FIBROSIS.A CLINICAL, RADIOLOGICAL, AND PATHOLOGICAL STUDY BASED ON 45 PATIENTS. , 1964, The Quarterly journal of medicine.

[26]  J A Waldron,et al.  Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. , 1997, American journal of respiratory and critical care medicine.

[27]  P. Grenier,et al.  Chronic diffuse interstitial lung disease: diagnostic value of chest radiography and high-resolution CT. , 1991, Radiology.

[28]  D. E. Rogers,et al.  Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. , 1959, The Journal of clinical investigation.

[29]  P. Friedman,et al.  Chest radiography in desquamative interstitial pneumonitis: a review of 37 patients. , 1980, AJR. American journal of roentgenology.

[30]  R. Chapela,et al.  Colchicine, D-penicillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis: a controlled clinical trial. , 1998, Chest.

[31]  D. Bassett,et al.  Influenza virus infection, ozone exposure, and fibrogenesis. , 1990, The American review of respiratory disease.

[32]  B. P. Hughes.  Some Biochemical Aspects of the Myopathies , 1965, Postgraduate medical journal.

[33]  A. Murphy,et al.  Familial fibrosing alveolitis , 1981, Irish journal of medical science.

[34]  A. Gulsvik,et al.  High-dose intravenous methylprednisolone pulse therapy as initial treatment in cryptogenic fibrosing alveolitis. A pilot study. , 1986, Respiration; international review of thoracic diseases.

[35]  V. Petkov,et al.  A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. , 1999, The New England journal of medicine.

[36]  E. Cameron,et al.  Efficacy of video assisted thoracoscopic lung biopsy: an historical comparison with open lung biopsy. , 1994, Thorax.

[37]  S. Lareau,et al.  Pulmonary rehabilitation , 2001, Breathe.

[38]  J. Weeks,et al.  Antibodies in some chronic fibrosing lung diseases , 1971, Clinical allergy.

[39]  C. Selby,et al.  Accuracy of the typical computed tomographic appearances of fibrosing alveolitis. , 1993, Thorax.

[40]  F. Ognibene,et al.  Lymphoid pneumonitis in 50 adult patients infected with the human immunodeficiency virus: lymphocytic interstitial pneumonitis versus nonspecific interstitial pneumonitis. , 1992, Human pathology.

[41]  B. Heard,et al.  Cryptogenic fibrosing alveolitis: assessment by graded trephine lung biopsy histology compared with clinical, radiographic, and physiological features. , 1981, British journal of diseases of the chest.

[42]  D. Carrigan,et al.  Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation , 1991, The Lancet.

[43]  T. Colby,et al.  Pathologic manifestations of bronchiolitis, constrictive bronchiolitis, cryptogenic organizing pneumonia, and diffuse panbronchiolitis. , 1993, Clinics in chest medicine.

[44]  R. Hubbard,et al.  Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis , 1996, The Lancet.

[45]  I. D. Johnston,et al.  British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. , 1997, Thorax.

[46]  G. Raghu,et al.  Interstitial lung disease: a diagnostic approach. Are CT scan and lung biopsy indicated in every patient? , 1995, American journal of respiratory and critical care medicine.

[47]  C. Kozinetz,et al.  Factors influencing survival in children with chronic interstitial lung disease. , 1997, American journal of respiratory and critical care medicine.

[48]  N. Müller,et al.  Cryptogenic organizing pneumonia: CT findings in 43 patients. , 1994, AJR. American journal of roentgenology.

[49]  G. Raghu,et al.  Pulmonary fibrosis following pneumonia due to acute Legionnaires' disease. Clinical, ultrastructural, and immunofluorescent study. , 1987, Chest.

[50]  A. Woodcock,et al.  Viruses and idiopathic pulmonary fibrosis. , 1997, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[51]  J. Ikezoe,et al.  High-resolution CT and pulmonary function tests in collagen vascular disease: comparison with idiopathic pulmonary fibrosis. , 1994, European journal of radiology.

[52]  K. Pinsker,et al.  Usual interstitial pneumonia following Texas A2 influenza infection. , 1981, Chest.

[53]  A. Fine,et al.  Potential therapeutic initiatives for fibrogenic lung diseases. , 1995, Chest.

[54]  K. Ohta,et al.  Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. , 1992, The American review of respiratory disease.

[55]  J. Samet,et al.  Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Collaborating Centers. , 2000, American journal of epidemiology.

[56]  E. Block,et al.  Clinical role of bronchoalveolar lavage in adults with pulmonary disease. , 1990, The American review of respiratory disease.

[57]  W. Roberts,et al.  Small airways in idiopathic pulmonary fibrosis. Comparison of morphologic and physiologic observations. , 1977, The Journal of clinical investigation.

[58]  S. Swensen,et al.  Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group. , 1998, American journal of respiratory and critical care medicine.

[59]  D M Hansell,et al.  Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. , 1993, AJR. American journal of roentgenology.

[60]  V. Faber,et al.  Computed Tomography of the Lungs in Acquired Immunodeficiency Syndrome , 1988, Acta radiologica.

[61]  R R Miller,et al.  Hypersensitivity pneumonitis: evaluation with CT. , 1989, Radiology.

[62]  N. Müller,et al.  Acute interstitial pneumonia: radiographic and CT findings in nine patients. , 1993, Radiology.

[63]  D. Schwartz,et al.  Determinants of survival in idiopathic pulmonary fibrosis. , 1994, American journal of respiratory and critical care medicine.

[64]  C. Kozinetz,et al.  Diagnostic value of transbronchial, thoracoscopic, and open lung biopsy in immunocompetent children with chronic interstitial lung disease. , 1997, The Journal of pediatrics.

[65]  J. Lynch,et al.  Immunosuppressive treatment of the pulmonary manifestations of progressive systemic sclerosis. , 1995, Current opinion in rheumatology.

[66]  J. Remy,et al.  Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation. , 1993, Radiology.

[67]  M. Kamboh,et al.  Genetic studies in familial fibrosing alveolitis. Possible linkage with immunoglobulin allotypes (Gm). , 1986, Chest.

[68]  C. Pantin,et al.  Measures of the inflammatory response in cryptogenic fibrosing alveolitis. , 1988, The American review of respiratory disease.

[69]  R. Crystal,et al.  Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. , 1984, The New England journal of medicine.

[70]  C. Gallagher,et al.  Oxygen improves maximal exercise performance in interstitial lung disease. , 1994, American journal of respiratory and critical care medicine.

[71]  J. Britton,et al.  Atopy as a risk factor for cryptogenic fibrosing alveolitis. , 1994, Respiratory medicine.

[72]  E. Taskinen,et al.  Prognosis of cryptogenic fibrosing alveolitis. , 1983, Thorax.

[73]  D. Aberle,et al.  Asbestos-related pleural and parenchymal fibrosis: detection with high-resolution CT. , 1988, Radiology.

[74]  D. Voelker,et al.  Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A. , 1991, The American review of respiratory disease.

[75]  J. Darbyshire,et al.  Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. , 1989, Thorax.

[76]  B. Burrows,et al.  Cryptogenic fibrosing alveolitis: clinical features and their influence on survival , 1980, Thorax.

[77]  A. Salsbury,et al.  Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features , 1980, Thorax.

[78]  I. D. Johnston,et al.  Idiopathic pulmonary fibrosis and hepatitis C virus infection. , 1993, The American review of respiratory disease.

[79]  J. Myers,et al.  Respiratory bronchiolitis causing interstitial lung disease. A clinicopathologic study of six cases. , 1987, The American review of respiratory disease.

[80]  D. Schwartz,et al.  Outcome of subjects with idiopathic pulmonary fibrosis who fail corticosteroid therapy. Implications for further studies. , 1993, Chest.

[81]  S. Freedman,et al.  The ventilatory response to CO 2 of patients with diffuse pulmonary infiltrations or fibrosis. , 1972, Clinical science.

[82]  J. Samet,et al.  Corticosteroids and the treatment of idiopathic pulmonary fibrosis. Past, present, and future. , 1996, Chest.

[83]  R. Crystal,et al.  Distribution of HLA antigens in idiopathic pulmonary fibrosis. , 2015, The American review of respiratory disease.

[84]  H. Sieker,et al.  Positive antinuclear factor in patients with unexplained pulmonary fibrosis. , 1969, Annals of internal medicine.

[85]  G. Laurent,et al.  Serum type III procollagen peptide concentration in cryptogenic fibrosing alveolitis and its clinical relevance. , 1984, Thorax.

[86]  H. Hartelius.  Computed Tomography in Opportunistic Lung Infections , 1988, Acta radiologica.

[87]  N. Müller,et al.  Desquamative Interstitial Pneumonia : Computed Tomographic Findings before and after Treatment with Corticosteroids , 1988 .

[88]  H. Reynolds,et al.  Diagnostic and management strategies for diffuse interstitial lung disease. , 1998, Chest.

[89]  N L Müller,et al.  Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. , 1989, Radiology.

[90]  E. Hershfield,et al.  Chronic obstructive pulmonary disease following idiopathic pulmonary fibrosis. , 1980, Chest.

[91]  T. Creer,et al.  Health-related quality-of-life assessment in medical care. , 1995, Disease-a-month : DM.

[92]  S. Yeh,et al.  99Tcm-HMPAO and 99Tcm-DTPA radioaerosol clearance measurements in idiopathic pulmonary fibrosis. , 1995, Nuclear medicine communications.

[93]  P. Howard,et al.  Hypothesis: exposure to solvents may cause fibrosing alveolitis. , 1994, The European respiratory journal.

[94]  H. Sieker,et al.  Pathogenetic mechanisms of interstitial pulmonary fibrosis in patients with serum antinuclear factor. A histologic and clinical correlation. , 1972, The American journal of medicine.

[95]  R. D. du Bois,et al.  Prediction of disease progression in idiopathic pulmonary fibrosis. , 1994, The European respiratory journal.

[96]  N. Müller,et al.  Usual interstitial pneumonia: correlation of CT with clinical, functional, and radiologic findings. , 1987, Radiology.

[97]  J. Myers,et al.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. , 1998, American journal of respiratory and critical care medicine.

[98]  T. McLoud,et al.  Normal chest roentgenograms in chronic diffuse infiltrative lung disease. , 1978, The New England journal of medicine.

[99]  J D Fulmer,et al.  Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis. , 1979, The Journal of clinical investigation.

[100]  Approaches to the treatment of pulmonary fibrosis. , 1995, American journal of respiratory and critical care medicine.

[101]  M. Warwick,et al.  HLA IN CRYPTOGENIC FIBROSING ALVEOLITIS , 1978, The Lancet.

[102]  I. D. Johnston,et al.  Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study. , 1998, American journal of respiratory and critical care medicine.

[103]  H. Klech,et al.  Clinical guidelines and indications for bronchoalveolar lavage (BAL): Report of the European Society of Pneumology Task Group on BAL. , 1990, The European respiratory journal.

[104]  C. Gallagher,et al.  Low-dose nebulized morphine does not improve exercise in interstitial lung disease. , 1995, American journal of respiratory and critical care medicine.

[105]  A. Grassino,et al.  Breathing Pattern in Sarcoidosis and Idiopathic Pulmonary Fibrosis , 1986, Annals of the New York Academy of Sciences.

[106]  G. Grau,et al.  Effective treatment of the pulmonary fibrosis elicited in mice by bleomycin or silica with anti-CD-11 antibodies. , 1993, The American review of respiratory disease.

[107]  R. Crystal,et al.  Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members. , 1986, The New England journal of medicine.

[108]  Rosenberger Dm.  Inherited forms of interstitial lung disease. , 1982 .

[109]  T. King,et al.  Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. , 1990, The American journal of medicine.

[110]  K. Moser,et al.  Management for interstitial lung disease. State of the art. , 1989, Chest.

[111]  F. Askin.  Acute interstitial pneumonia: histopathologic patterns of acute lung injury and the Hamman-Rich syndrome revisited. , 1993, Radiology.

[112]  U. Cegla.  [Idiopathic fibrosing alveolitis]. , 1977, Fortschritte der Medizin.

[113]  J. Curtis,et al.  The sensitivity of high-resolution CT in detecting idiopathic pulmonary fibrosis proved by open lung biopsy. A prospective study. , 1995, Chest.

[114]  A. Fishman,et al.  THE REGULATION OF VENTILATION IN DIFFUSE PULMONARY FIBROSIS. , 1965, The American journal of medicine.

[115]  A. Theofilopoulos,et al.  Circulating immune complexes in the idiopathic interstitial pneumonias. , 1978, The New England journal of medicine.

[116]  T. Colby,et al.  Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. , 1989, Mayo Clinic proceedings.

[117]  L. Lanza,et al.  VATS increases costs in patients undergoing lung biopsy for interstitial lung disease. , 1994, The Annals of thoracic surgery.

[118]  J. Barberà,et al.  Pulmonary function tests and CT scan in the management of idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.

[119]  Keith McNeil,et al.  International guidelines for the selection of lung transplant candidates. The American Society for Transplant Physicians (ASTP)/American Thoracic Society(ATS)/European Respiratory Society(ERS)/International Society for Heart and Lung Transplantation(ISHLT). , 1998, American journal of respiratory and critical care medicine.

[120]  D. Hansell,et al.  Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison. , 1997, American journal of respiratory and critical care medicine.

[121]  N. Müller,et al.  Desquamative interstitial pneumonia: thin-section CT findings in 22 patients. , 1993, Radiology.

[122]  R. Baughman,et al.  Use of intermittent, intravenous cyclophosphamide for idiopathic pulmonary fibrosis. , 1992, Chest.

[123]  M. Link,et al.  Giant cell pneumonia caused by parainfluenza type 3 in a patient with acute myelomonocytic leukemia. , 1987, Archives of pathology & laboratory medicine.

[124]  J. Yernault,et al.  Diffusing Properties and Elastic Properties in Interstitial Diseases of the Lung1 , 1975 .

[125]  F. Basset,et al.  Chest radiological features of pulmonary histiocytosis X: a report based on 50 adult cases. , 1982, Thorax.

[126]  V. Ferrans,et al.  Interstitial lung disease: current concepts of pathogenesis, staging and therapy. , 1981, The American journal of medicine.

[127]  N. Müller,et al.  Disease progression in usual interstitial pneumonia compared with desquamative interstitial pneumonia. Assessment with serial CT. , 1996, Chest.

[128]  A. Katzenstein,et al.  Nonspecific Interstitial Pneumonia/Fibrosis: Histologic Features and Clinical Significance , 1994, The American journal of surgical pathology.

[129]  R. McIntyre,et al.  Comparison of video thoracoscopic lung biopsy to open lung biopsy in the diagnosis of interstitial lung disease. , 1993, Chest.

[130]  K P Offord,et al.  Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.

[131]  S. Noma,et al.  Serial changes of cystic air spaces in fibrosing alveolitis: a CT-pathological study. , 1995, Clinical radiology.

[132]  T. Colby.  Pathologic aspects of bronchiolitis obliterans organizing pneumonia. , 1992, Chest.

[133]  R. Chapela,et al.  Mortality in Mexican patients with chronic pigeon breeder's lung compared with those with usual interstitial pneumonia. , 1993, The American review of respiratory disease.

[134]  M A Schork,et al.  Idiopathic pulmonary fibrosis: predicting response to therapy and survival. , 1998, American journal of respiratory and critical care medicine.

[135]  G. Raghu,et al.  Treatment of Idiopathic Pulmonary Fibrosis with a New Antifibrotic Agent , Pirfenidone Results of a Prospective , Open-label Phase II Study , 1999 .

[136]  I. D. Johnston,et al.  Rising mortality from cryptogenic fibrosing alveolitis. , 1990, BMJ.

[137]  M. Schwarz,et al.  Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. , 1987, The American review of respiratory disease.

[138]  A. Liebow,et al.  DESQUAMATIVE INTERSTITIAL PNEUMONIA. , 1965, The American journal of medicine.

[139]  N. Müller,et al.  Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. , 1987, Radiology.

[140]  R. Kornbluth,et al.  Respiratory control in diffuse interstitial lung disease and diseases of the pulmonary vasculature. , 1980, Clinics in chest medicine.

[141]  J. Scadding,et al.  Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs) , 1967, Thorax.

[142]  D. Coultas,et al.  Accuracy of mortality data for interstitial lung diseases in New Mexico, USA. , 1996, Thorax.

[143]  M. Kitaichi,et al.  Bronchiolitis obliterans organizing pneumonia. Clinical features and differential diagnosis. , 1992, Chest.

[144]  S. Swensen,et al.  Diffuse lung disease: diagnostic accuracy of CT in patients undergoing surgical biopsy of the lung. , 1997, Radiology.

[145]  D. Hyde,et al.  Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. , 1993, Thorax.

[146]  D. Aberle,et al.  Computed tomography in the diagnosis of asbestos‐related thoracic disease , 1989, Journal of thoracic imaging.

[147]  N. Müller,et al.  MRI of Infiltrative Lung Disease: Comparison with Pathologic Findings , 1994, Journal of computer assisted tomography.

[148]  N. Cherniack,et al.  Occlusion pressure and breathing pattern in patients with interstitial lung disease. , 2015, The American review of respiratory disease.

[149]  G. Gamsu,et al.  CT quantification of interstitial fibrosis in patients with asbestosis: a comparison of two methods. , 1995, AJR. American journal of roentgenology.

[150]  R. Crystal,et al.  Colchicine suppresses the release of fibroblast growth factors from alveolar macrophages in vitro. The basis of a possible therapeutic approach ot the fibrotic disorders. , 1988, The American review of respiratory disease.

[151]  R R Miller,et al.  The CT findings of pulmonary sarcoidosis: analysis of 25 patients. , 1989, AJR. American journal of roentgenology.

[152]  G. Raghu,et al.  Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. , 1991, The American review of respiratory disease.

[153]  Choon-Sik Park,et al.  Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients. , 1995, Radiology.

[154]  G. Raghu,et al.  High resolution CT in respiratory bronchiolitis-associated interstitial lung disease. , 1993, Journal of computer assisted tomography.

[155]  B. Burrows,et al.  Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival , 1980, Thorax.

[156]  G. Bradley,et al.  Regulation of breathing during exercise in normal subjects and in chronic lung disease. , 1976, Clinical science and molecular medicine.

[157]  L. Ackerson,et al.  Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology. , 1996, American journal of respiratory and critical care medicine.

[158]  T. Takishima,et al.  Pulmonary emphysema followed by pulmonary fibrosis of undetermined cause. , 1993, Respiration; international review of thoracic diseases.

[159]  T. Schaberg,et al.  Lung function tests in patients with idiopathic pulmonary fibrosis. Are they helpful for predicting outcome? , 1997, Chest.

[160]  A. Cantin,et al.  Extracellular glutathione suppresses human lung fibroblast proliferation. , 1990, American journal of respiratory cell and molecular biology.

[161]  C. Uh.  [Treatment of idiopathic fibrosing alveolitis. Therapeutic experiences with azathioprine-prednisolone and D-penicillamine-prednisolone combination therapy]. , 1977 .

[162]  Mycoplasma pneumonia with fulminant evolution into diffuse interstitial fibrosis. , 1980 .

[163]  M. Schwarz,et al.  A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. , 1986, The American review of respiratory disease.

[164]  T. Colby,et al.  Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. , 1998, The European respiratory journal.

[165]  A. Nicholson,et al.  Pulmonary sarcoidosis mimicking cryptogenic fibrosing alveolitis on CT. , 1996, Clinical radiology.

[166]  C. Gallagher,et al.  Role of hypoxemia and pulmonary mechanics in exercise limitation in interstitial lung disease. , 1996, American journal of respiratory and critical care medicine.

[167]  R. D. du Bois.  Diffuse lung disease: a view for the future. , 1997, Sarcoidosis Vasculities and Diffuse Lung Diseases.

[168]  R. Crystal,et al.  Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. , 1987, The Journal of clinical investigation.

[169]  A. Salsbury,et al.  Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. , 1980, Thorax.

[170]  D. Schwartz,et al.  Determinants of progression in idiopathic pulmonary fibrosis. , 1994, American journal of respiratory and critical care medicine.

[171]  N L Müller,et al.  Fibrosing alveolitis: chest radiography and CT as predictors of clinical and functional impairment at follow-up in 26 patients. , 1992, Radiology.

[172]  Winterbauer Rh,et al.  Clinical course, management, and long-term sequelae of respiratory failure due to influenza viral pneumonia. , 1977 .

[173]  C. Vogelmeier,et al.  Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression. , 1997, American journal of respiratory and critical care medicine.

[174]  D. Geddes,et al.  α1-ANTITRYPSIN PHENOTYPES IN FIBROSING ALVEOLITIS AND RHEUMATOID ARTHRITIS , 1977, The Lancet.

[175]  J. Samet,et al.  Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts , 1998, Thorax.

[176]  D. Hansell,et al.  The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis. , 1993, The American review of respiratory disease.

[177]  G. Raghu,et al.  Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.

[178]  T. Chinet,et al.  Mechanisms of increased epithelial lung clearance of DTPA in diffuse fibrosing alveolitis. , 1994, The European respiratory journal.

[179]  H. Spiera,et al.  SEROLOGIC FACTORS IN IDIOPATHIC DIFFUSE INTERSTITIAL PULMONARY FIBROSIS. , 1965, The American journal of medicine.

[180]  R. G. Parrish,et al.  Pulmonary fibrosis deaths in the United States, 1979-1991. An analysis of multiple-cause mortality data. , 1996, American journal of respiratory and critical care medicine.

[181]  R. Loddenkemper,et al.  Clinical and radiologic features, lung function and therapeutic results in pulmonary histiocytosis X. , 1993, Respiration; international review of thoracic diseases.

[182]  A. Woodcock,et al.  Does the treatment of cryptogenic fibrosing alveolitis influence prognosis? , 1996, Respiratory medicine.

[183]  R. Hubbard,et al.  Alpha1-antitrypsin phenotypes in patients with cryptogenic fibrosing alveolitis: a case-control study. , 1997, The European respiratory journal.

[184]  E. Rosenow,et al.  Lymphocytic interstitial pneumonitis. Review of 13 cases. , 1978, Annals of internal medicine.

[185]  L. Avioli,et al.  Idiopathic Pulmonary Fibrosis , 1981 .

[186]  R. Rudd,et al.  Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. , 1981, The American review of respiratory disease.

[187]  J A Merchant,et al.  High-resolution CT-derived measures of lung density are valid indexes of interstitial lung disease. , 1994, Journal of applied physiology.

[188]  L. Watters.  Genetic Aspects of Idiopathic Pulmonary Fibrosis and Hypersensitivity Pneumonitis , 1986 .

[189]  J. McDougall,et al.  Colchicine in the treatment of pulmonary fibrosis. , 1993, Chest.

[190]  M. Akira,et al.  Idiopathic pulmonary fibrosis: progression of honeycombing at thin-section CT. , 1993, Radiology.

[191]  G. Davis.  Bronchoalveolar Lavage in Interstitial Lung Disease , 1994 .

[192]  C. Siegel,et al.  Isolation of measles virus in primary rhesus monkey cells from a child with acute interstitial pneumonia who cytologically had giant-cell pneumonia without a rash. , 1990, American journal of clinical pathology.

[193]  J. Myers,et al.  Acute Interstitial Pneumonia: A Clinicopathologic, Ultrastmctural, and Cell Kinetic Study , 1986, The American journal of surgical pathology.

[194]  A. Raap,et al.  Three sensitive methods for the detection of cytomegalovirus in lung tissue of patients with interstitial pneumonitis. , 1990, American journal of clinical pathology.

[195]  I. D. Johnston,et al.  What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. , 1990, BMJ.

[196]  P. Venge,et al.  The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function. , 1989, The American review of respiratory disease.

[197]  L. Frank,et al.  Effects of the 21‐aminosteroid, U74389F, on bleomycin‐induced pulmonary fibrosis in rats , 1994, Critical care medicine.

[198]  D. Lynch,et al.  Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? , 1995, AJR. American journal of roentgenology.

[199]  G. Hunninghake,et al.  Prognostic role of eosinophils in pulmonary fibrosis. , 1987, Chest.

[200]  M. Yamaguchi,et al.  Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. , 1994, American journal of respiratory and critical care medicine.

[201]  A. Woodcock,et al.  Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. , 1995, Thorax.

[202]  H. Itoh,et al.  Usual interstitial pneumonia: histologic correlation with high-resolution CT. , 1992, Radiology.

[203]  R. Crystal,et al.  Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. , 1989, The American review of respiratory disease.

[204]  N. Anthonisen,et al.  Role of vagal airway reflexes in control of ventilation in pulmonary fibrosis. , 1981, Clinical science.

[205]  L. Fasano,et al.  Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis. , 1996, Thorax.

[206]  G. Jakab.  Sequential virus infections, bacterial superinfections, and fibrogenesis. , 1990, The American review of respiratory disease.

[207]  D. Lynch,et al.  Hypersensitivity pneumonitis: sensitivity of high-resolution CT in a population-based study. , 1992, AJR. American journal of roentgenology.

[208]  S. Wagenaar,et al.  Relationship between cells obtained by bronchoalveolar lavage and survival in idiopathic pulmonary fibrosis. , 1995, Thorax.

[209]  D. Hansell,et al.  Accuracy of the typical computed tomographic appearances of fibrosing alveolitis. , 1993, Thorax.

[210]  B. Heard,et al.  The prognosis of cryptogenic fibrosing alveolitis , 1972, British medical journal.

[211]  N. Pride,et al.  Lung distensibility. The static pressure-volume curve of the lungs and its use in clinical assessment. , 1976, British journal of diseases of the chest.

[212]  G. Raghu,et al.  Idiopathic Pulmonary Fibrosis: Current Clinical Concepts and Challenges in Management , 1994 .